These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21384080)

  • 1. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.
    Hurtado B; Muñoz X; Recarte-Pelz P; García N; Luque A; Krupinski J; Sala N; García de Frutos P
    Thromb Haemost; 2011 May; 105(5):873-82. PubMed ID: 21384080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis.
    Hurtado B; Abasolo N; Muñoz X; García N; Benavente Y; Rubio F; García de Frutos P; Krupinski J; Sala N
    Thromb Haemost; 2010 Sep; 104(3):592-8. PubMed ID: 20664904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily.
    Perez F; Iribarren ML; Olexen CM; Ruera CN; Errasti AE; Guzman L; Garbi L; Carrera Silva EA; Chirdo FG
    Clin Immunol; 2024 Jun; 263():110202. PubMed ID: 38575045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
    Shafit-Zagardo B; Gruber RC; DuBois JC
    Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
    Al Kafri N; Hafizi S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
    Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
    Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
    Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
    J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
    Ray AK; DuBois JC; Gruber RC; Guzik HM; Gulinello ME; Perumal G; Raine C; Kozakiewicz L; Williamson J; Shafit-Zagardo B
    Glia; 2017 Dec; 65(12):2051-2069. PubMed ID: 28925029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gas6/TAM System and Multiple Sclerosis.
    Bellan M; Pirisi M; Sainaghi PP
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.
    Hafizi S; Dahlbäck B
    FEBS J; 2006 Dec; 273(23):5231-44. PubMed ID: 17064312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
    Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
    PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
    PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation.
    Lee IJ; Hilliard BA; Ulas M; Yu D; Vangala C; Rao S; Lee J; Gadegbeku CA; Cohen PL
    Clin Immunol; 2015 Jun; 158(2):231-41. PubMed ID: 25814173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?
    Garbin U; Baggio E; Stranieri C; Pasini A; Manfro S; Mozzini C; Vallerio P; Lipari G; Merigo F; Guidi G; Cominacini L; Fratta Pasini A
    Cardiovasc Res; 2013 Jan; 97(1):125-33. PubMed ID: 22997156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Dave F; Herrera K; Lockley A; van de Weijer LL; Henderson S; Sofela AA; Hook L; Adams CL; Ercolano E; Hilton DA; Maze EA; Kurian KM; Ammoun S; Hanemann CO
    Oncogene; 2024 Oct; 43(41):3049-3061. PubMed ID: 39179860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Tutusaus A; Morales A; García de Frutos P; Marí M
    Semin Liver Dis; 2024 Feb; 44(1):99-114. PubMed ID: 38395061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.